Companies / NexImmune, Inc.
NexImmune, Inc.
NEXICIK 1538210
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 17, 2021 | Verstandig Grant Director | Buy Open-market buy | Common Stock | $2.98M | +175K +32.41% | 714,895 | high |
| Feb 17, 2021 | Barer Sol J Director | Buy Open-market buy | Common Stock | $1.02M | +60K +4.06% | 1,538,013 | high |
| Mar 25, 2022 | Verstandig Grant Director | Buy Open-market buy | Common Stock | $544.9K | +132K +17.44% | 886,512 | high |
| Dec 21, 2021 | Barer Sol J Director | Exercise Option exercise | Common Stock | $258.5K | +50K +3.66% | 1,417,814 | low |
| Dec 21, 2021 | Roemer Alan S. Director | Exercise Option exercise | Common Stock | $182.7K | +42K +27.66% | 195,641 | low |
| Mar 30, 2023 | Barer Sol J Director | Buy Open-market buy | Common Stock | $164.1K | +400K +22.00% | 2,217,814 | medium |
| Mar 24, 2022 | Verstandig Grant Director | Buy Open-market buy | Common Stock | $134.0K | +40K +5.59% | 754,890 | medium |
| Jun 2, 2022 | Verstandig Grant Director | Buy Open-market buy | Common Stock | $106.7K | +48K +4.83% | 1,038,619 | medium |